bepmed |

2002161136
l 2002
US

1141. Polylactide/dextran graft co-polymers for biomaterial and tissue engineering applications

Abstract

A biocompatible, biodegradable, copolymer is prepared from cross-linking a polylactic acid with a polysaccharide such as dextran. The resulting copolymer is a biodegradable hydrogel or...

13:58 / Biomaterial / methods

2002188240
l 2002
US

1142. Process and apparatus for utilization of in vivo extracted plasma with tissue engineering devices, bioreactors, artificial organs, and cell therapy applications

Abstract

The present invention is directed to a method of treating cells, tissues or organs using in vivo plasma separation by implanting a plasma separation filter...

13:58 / cells / organ

6416995
l 2002
US

1143. Bioreactor mediated recellularization of natural and tissue engineered vascular grafts

Abstract

The invention provides a device and process for recellularizing essentially acellular or devitalized tissue grafts, including for example essentially acellular or devitalized vascular tissue grafts,...

13:58 / cells / methods

6423818
l 2002
US

1144. Coumarin endcapped absorbable polymers

Abstract

The present invention includes photocurable, liquid polymers incorporating coumarin ester endgroups into their molecular structure, which polymers are crosslinked upon irradiation with ultraviolet light by...

13:58 / methods / Scaffolds

2002015719
l 2002
US

1145. Methods and reagents for tissue engineering of cartilage in vitro

Abstract

The present invention makes available an optimal concentration of a hedgehog polypeptide for modulating growth and/or cartilage production by chondrocytes. The present invention allows for...

13:58 / cells / methods

2002046410
l 2002
US

1146. Method for generating immune-compatible cells and tissues using nuclear transfer techniques

Abstract

This invention relates to methods for making immune compatible tissues and cells for the purpose of transplantation and tissue engineering, using the techniques of nuclear...

13:58 / cells / methods

2002177224
l 2002
US

1147. Tissue engineering enhanced by the transfer of a growth factor gene

Abstract

Tissue engineered constructs including a matrix and cells transfected with a gene for a growth factor. The constructs may be implanted into a tissue site,...

13:58 / cells / methods

6376742
l 2002
US

1148. In vivo tissue engineering with biodegradable polymers

Abstract

The present invention relates generally to the utilization of in situ polymers or copolymers to form a porous microcellular scaffold for the delivery, attachment, housing,...

13:58 / cells / methods

6468731
l 2002
US

1149. Enzyme-mediated modification of fibrin for tissue engineering: incorporation of proteins

Abstract

Disclosed are materials that may be used in the design of improved devices and wound treatment platforms though covalent and/or non-covalent attachment of bioactive proteins....

13:58 / growth factors / methods

6337198
l 2002
US

1150. Porous polymer scaffolds for tissue engineering

Abstract

Biodegradable and biocompatible porous scaffolds characterized by a substantially continuous polymer phase, having a highly interconnected bimodal distribution of open pore sizes with rounded large...

13:58 / methods / Scaffolds

Author: admin

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract